Work

Inavolisib-based Combination Therapy for the Treatment of PIK3CAMutated HR+/HER2- Breast Cancer: An Overview

Year: 2026

Type: article

Source: Mini-Reviews in Medicinal Chemistry

DOI: 10.2174/0113895575418114251210151424

Authors: Sushmita Bhatia, Neha Bhatia, Suresh Thareja

Institution: Central University of Punjab

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7133138470

FWCI:

Cites: 1

Cited by:

Related to: